alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
NO. 12-23-00312-CV 

IN THE COURT OF APPEALS

TWELFTH COURT OF APPEALS DISTRICT

TYLER, TEXAS

CORNELIUS BUTLER, 

INDIVIDUALLY AND ON BEHALF 

OF THE ESTATE OF BETTY 

BUTLER, 

APPELLANT

V.

TYLER OPS LTC., INC. D/B/A PETAL 

HILL NURSING & 

REHABILITATION, 

APPELLEE

§

§

§

APPEAL FROM THE 241ST 

JUDICIAL DISTRICT COURT

SMITH COUNTY, TEXAS

MEMORANDUM OPINION

PER CURIAM

This appeal is being dismissed for failure to comply with a requirement of the appellate

rules, a court order, or a notice from the clerk requiring a response or other action within a 

specified time. See TEX. R. APP. P. 42.3(c). 

A party who is not excused by statute or the appellate rules from paying costs must pay--

at the time an item is presented for filing--whatever fees are required by statute or Texas

Supreme Court order. TEX. R. APP. P. 5; see TEX. R. APP. P. 20.1. An appellate court may 

enforce Rule 5 by any order that is just. TEX. R. APP. P. 5. After giving ten days’ notice, an

appellate court may dismiss an appeal because the appellant failed to comply with a requirement 

of the appellate rules, a court order, or a notice from the clerk requiring a response or other 

action within a specified time. TEX. R. APP. P. 42.3(c). 

On December 15, 2023, the Clerk of this Court notified Appellant, Cornelius Butler, 

Individually and on Behalf of the Estate of Betty Butler, that the filing fee in this appeal is due
2 

and that the appeal would be subject to dismissal if the fee was not paid on or before December 

27. The date for remitting the filing fee passed, and Appellant has not paid the fee or otherwise

shown that he is excused from paying the fee.

1

Because Appellant failed, after notice, to comply with Rule 5, the appeal is dismissed.

2

See TEX. R. APP. P. 42.3(c). 

Opinion delivered January 10, 2024. 

Panel consisted of Worthen, C.J., Hoyle, J., and Neeley, J.

1 The case information sheet from the Smith County District Clerk’s Office reflects that Appellant was not 

declared indigent in the trial court.

2 Nor has Appellant filed the required docketing statement. See TEX. R. APP. P. 32.1.
COURT OF APPEALS

TWELFTH COURT OF APPEALS DISTRICT OF TEXAS

JUDGMENT 

JANUARY 10, 2024 

NO. 12-23-00312-CV

CORNELIUS BUTLER, INDIVIDUALLY AND ON BEHALF OF THE ESTATE OF 

BETTY BUTLER, 

Appellant 

V.

TYLER OPS LTC., INC. D/B/A PETAL HILL NURSING & REHABILITATION, 

Appellee

Appeal from the 241st District Court 

of Smith County, Texas (Tr.Ct.No. 21-1988-C) 

THIS CAUSE came to be heard on the appellate record; and the same being considered, 

it is the opinion of this Court that this appeal should be dismissed. 

It is therefore ORDERED, ADJUDGED and DECREED by this Court that the appeal be, 

and the same is, hereby dismissed; and that this decision be certified to the court below for 

observance. 

By per curiam opinion. 

Panel consisted of Worthen, C.J., Hoyle, J. and Neeley, J.
No. 12-7412.

#### Robinson *v.*Bloomberg, Mayor of the City of New York, et al.

C. A. 2d Cir. Certiorari denied.
<PAGE>

                                                                              15


                                                                    EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350

          In connection with the Quarterly Report of Mills Music Trust (the
"Trust") on Form 10-Q for the fiscal quarter ended September 30, 2007, as filed
with the Securities and Exchange Commission (the "Report"), the undersigned
certifies, pursuant to 18 U.S.C. Section 1350, that to my knowledge:

          1. The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

          2. The information contained in the Report fairly presents, in all
material respects, the financial condition* and results of operations of the
Trust.


Date: November 14, 2007                 /s/ Joel Faden
                                        ----------------------------------------
                                        Joel Faden, Joel Faden & Company, Inc.
                                        Chief Financial Individual
                                        Providing accounting services

*    The statements of cash receipts and disbursements reflect only cash
     transactions and do not include transactions that would be recorded in
     financial statements presented on the accrual basis of accounting. The
     Trust is required to distribute all funds received after payment of
     expenses. Accordingly, the Trust has not prepared any statements of
     financial condition or cash flows.
Exhibit 10.34


 


	
   

  	
   

  	
  

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  ICO Satellite Services GP

  
	
   

  	
   

  	
  2300
  Carillon Point

  
	
   

  	
   

  	
  Kirkland WA 98033

  
	
   

  	
   

  	
  USA

  
	
   

  	
   

  	
   

  
	
   

  	
   

  	
  Tel    +1
  425828-8000

  
	
   

  	
   

  	
  Fax   +1 425 828-8021

  



 


December 16,
2005


 


David
Zufall


11005
Burywood Lane


Reston,
VA 20194


 


Dear
David,


 


I
am pleased to confirm our offer of employment as Senior Vice President, Ground
Segment. Your anticipated start date is January 1, 2005.


 


As
Senior Vice President, Ground Segment your monthly salary will be $18,000.
Payroll is processed monthly in arrears. We are pleased to offer you a 30%
annual bonus, guaranteed for the first year and determined by ICO’s board of
directors and management based on both personal and company performance in the
years following. You are eligible to receive 250,000 options vesting on a four
year schedule at 25% at the completion of each year. The vested options
will be exercisable at $4.75 per share.


 


You
will be eligible for four weeks (20 business days) of vacation per year accrued
at a rate of 1.67 days per month of employment as well as all company holidays.


 


ICO
currently offers all US employees the following benefits with 100% employer
paid premiums; group medical coverage through Aetna, group dental coverage
through Genworth Financial, group long-term disability, accidental death &
dismemberment and life insurance through Unum. ICO also offers a 401(k) plan
through Fidelity Investments. ICO contributes the equivalent of 12 % of your
basic monthly salary (within IRS regulatory limits) into your individual 401(k)
account which vests immediately. Details of these benefits are included in the
enclosed booklets. You are eligible to participate in each of these benefits,
though ICO reserves the right to change its benefit plans at ICO’s discretion.


 


We
look forward to a long and mutually beneficial employment relationship, but
wish to confirm that this is an employment-at-will relationship and ICO
recognizes that you have


 

















 


the right to terminate your employment with ICO at any time with or
without reason. Please be aware that ICO reserves a similar right to end the
employment relationship at any time with or without reason. This offer is in no
way meant to guarantee employment for any specific length of time.


 


Should
you have any questions, call me at 925 299 5330.


 


Please
confirm your acceptance of this offer by signing both copies of this letter and
returning one signed copy to me in the enclosed envelope.


 


Yours
Sincerely,


 


 


Craig
Jorgens


President


 


I
accept ICO’s offer of employment as outlined in this letter.


 


 


	
  /s/ David Zufall

  	
   

  	
  1/24/06

  	
   

  
	
  David Zufall

  	
  Date

  



 


* Offer includes salary
beginning 12/1/05
# EUR-Lex - 32010M6018 - EN

*|*

# 32010M6018

**Commission Decision of 29/11/2010 declaring a concentration to be compatible with the common market (Case No COMP/M.6018 - KKR / HGCAPITAL / ARCHANGEL) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic) **

*

*

(.PICT.) |EUROPEAN COMMISSION |

Brussels, 29.11.2010

SG-Greffe(2010) D/18924/18925

C(2010) 9140

PUBLIC VERSION

MERGER PROCEDURE ARTICLE 6(1)(b) DECISION

SIMPLIFIED PROCEDURE

To the notifying parties

Dear Madam(s) and/or Sir(s),

Subject: Case No COMP/M.6018 - KKR / HGCAPITAL / ARCHANGEL Notification of 22.10.2010 pursuant to Article 4 of Council Regulation (EC) No 139/2004 [1] Publication in the Official Journal of the European Union No C 296, 30.10.2010, p.14

1. On 22.10.2010, he European Commission received notification of a proposed concentration pursuant to Article 4 of the Merger Regulation by which the undertakings KKR & Co. L.P. ("KKR", United States) and HgCapital (United Kingdom) acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the undertaking Archangel AS ("Archangel", Norway) by way of purchase of shares.

2. The business activities of the undertakings concerned are:

- KKR: global alternative asset manager and provider of capital market solutions.

- HgCapital: private equity company, investing mainly in Europe.

- Archangel: provider, through its subsidiary Visma AS (Norway), of software solutions in the fields of accounting, finance, payroll, human resources, logistics, sales and customer management. Archangel is mainly active in Norway, Denmark, Finland, Sweden and the Netherlands.

3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5(c) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 [2] .

4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation.

For the European Commission, signed Alexander ITALIANER Director General

[1]OJ L 24, 29.1.2004, p. 1 ("the Merger Regulation"). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ("TFEU") has introduced certain changes, such as the replacement of "Community" by "Union" and "common market" by "internal market". The terminology of the TFEU will be used throughout this decision.

[2] OJ C 56, 5.3.2005, p. 32.
|                                                                                  
|----------------------------------------------------------------------------------
|                                                                                  
|View History:  Monthly  Annual Download Data (XLS File)                          
|View History:  Monthly  Annual                                                    
|View History:  Monthly  Annual                                                    
|View History:                                                                     
|                                                                                  
|No chart available.                                                               
|No chart available.                                                               
|                                                                                  
|                                                                                  
|Sault St Marie, MI Compressed Natural Gas Imports from Canada (Million Cubic Feet)
|                                                                                  

|Decade                                                                                                                            | Year-0 | Year-1 | Year-2 | Year-3 | Year-4 | Year-5 | Year-6 | Year-7 | Year-8 | Year-9
|--------------------------------------------------------------------------------------------------------------------------------- | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------ | ------
|2020's                                                                                                                            |        | 0      |        |        |        |        |        |        |        |       
|- = No Data Reported;  -- = Not Applicable;  NA = Not Available;  W = Withheld to avoid disclosure of individual company data.
|                                                                                                                                 
|Release Date: 7/31/2024                                                                                                          
|Next Release Date: 8/30/2024
[Federal Register Volume 63, Number 95 (Monday, May 18, 1998)]
[Notices]
[Pages 27304-27305]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-13150]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Allergy and Infectious Diseases Special Emphasis 
Panel (SEP) meetings:

    Name of SEP: NIAID Malaria Research and Reference Reagent 
Repository.
    Date: May 27, 1998.
    Time: 8:00 a.m. to Adjournment.

[[Page 27305]]

    Place: Holiday Inn, Georgetown, Mirage I Meeting Room, 2101 
Wisconsin Avenue, N.W., Washington, D.C. 20037, (202) 338-4600.
    Contact Person: Dr. Anna Ramsey-Ewing, Scientific Review Adm., 
6003 Executive Boulevard, Solar Bldg., Room 4C37, Bethesda, MD 
20892, (301) 435-8536.
    Purpose/Agenda: To evaluate contract proposals.

    Name of SEP: Malaria: Clinical Research and Trial Preparation 
Sites in Endemic Areas.
    Date: May 28-29, 1998.
    Time: 8:00 a.m. to Adjournment.
    Place: Holiday Inn, Georgetown, Mirage I Meeting Room, 2101 
Wisconsin Avenue, N.W., Washington, D.C. 20037, (202) 338-4600.
    Contact Person: Dr. Anna Ramsey-Ewing, Scientific Review Adm., 
6003 Executive Boulevard Solar Bldg., Room 4C37, Bethesda, MD 20892, 
(301) 435-8536.
    Purpose/Agenda: To evaluate contract proposals.
    These meetings will be closed in accordance with the provisions 
set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.
    This notice is being published less than 15 days prior to the 
meeting due to the urgent need to meet timing limitations imposed by 
the review and funding cycle.

(Catalog of Federal Domestic Assistance Programs Nos. 93.855, 
Immunology, Allergic and Immunologic Diseases Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health)

    Dated: May 11, 1998.
Anna Snouffer,
Acting Committee Management Officer, NIH.
[FR Doc. 98-13150 Filed 5-15-98; 8:45 am]
BILLING CODE 4140-01-M
**REGULATORY EVALUATION**

**Directorate Identifier:** 201 3

- NM

- 2 01

- AD

**Executive Order 12866:** Could the AD be considered a “significant regulatory action”? YES ( ) explain NO (X) **DOT Regulatory Policies and Procedures:** Is the AD significant? YES ( ) explain NO (X) **Regulatory Flexibility Act:** Will the AD have a significant economic impact on a substantial number of small entities? YES ( ) explain NO (X) **Intrastate Aviation in Alaska:** This AD could affect intrastate aviation in Alaska. I s it appropriate t o include specific requirements for aircraft operated in Alaska, where aviation might be the only mode of transportation? YES ( ) explain NO (X)
No. 12-8515.

#### Simmons *v.*United States.

Ct. App. D. C. Certiorari denied.
[Federal Register Volume 63, Number 96 (Tuesday, May 19, 1998)]
[Notices]
[Pages 27590-27591]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-13334]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on February 17, 1998, Roche 
Diagnostic Systems Inc., 1080 U.S. Highway 202, Somerville, New Jersey 
08876-3771, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)..........  I                          
Tetrahydrocannabinols (7370)...............  I                          
Phencyclidine (7471).......................  II                         
Benzoylecgonine (9180).....................  II                         
Methadone (9250)...........................  II                         
Morphine (9300)............................  II                         
------------------------------------------------------------------------


[[Page 27591]]

    The firm plans to manufacture small quantities of the listed 
controlled substances for incorporation in drug of abuse detection 
kits.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than July 20, 1998.

    Dated: May 7, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 98-13334 Filed 5-18-98; 8:45 am]
BILLING CODE 4410-09-M
#### In the Matter of Cecelia H. Lazich, Petitioner, v Gordon Burrows, Respondent.

[630 NYS2d 383]

—Proceeding pursuant to CPLR article 78, *inter alia,*to compel the respondent, a Justice of the Supreme Court, to comply with a decision and order of this Court, dated January 11, 1993, In *Lazich v Lazich*(189 AD2d 750), which, *inter alia,*directed the return of certain moneys to an escrow account, and a decision and order of this Court, dated August 9, 1993, in *Lazich v Vittoria & Parker*(196 AD2d 526), which, *inter alia,*remitted the matter to the Supreme Court, Westchester County, for a declaration of the rights of the parties to the proceeds of the escrow account, and for an immediate declaration of those rights.

Adjudged that the petition is denied and the proceeding is dismissed, without costs or disbursements.

The extraordinary remedy of mandamus will lie only to compel the performance of a ministerial act, and only where there exists a clear legal right to the relief sought *(see, Matter of Legal Aid Socy. v Scheinman,*53 NY2d 12, 16). In the decision and order of this Court dated August 9, 1993 *(Lazich v Vittoria & Parker,*196 AD2d 526, *supra),*this Court vacated so much of an order, as, *sua sponte,*consolidated a declaratory judgment action with a matrimonial action, and remitted the matter to the Supreme Court, Westchester County, for a determination of the rights of the parties to the proceeds of the sale of the former marital residence. This Court noted, however, that "it appears that the [declaratory judgment] action should be consolidated with the related matrimonial action”, but that *sua sponte*consolidation was improper *(Lazich v Vittoria & Parker, supra,*at 530).

*700Subsequently, on motion of one of the parties, the Supreme Court, Westchester County, did consolidate the two actions, but the consolidated action has not yet been brought to trial, through no fault of the respondent. We further note that insofar as the petitioner seeks to compel the plaintiff in the matrimonial action to return to the escrow account certain money that she allegedly has retained in violation of the court’s order dated January 11, 1993 *(Lazich v Lazich,*189 AD2d 750, *supra),*mandamus is not an appropriate remedy.

Accordingly, the application is denied. Sullivan, J. P., Balletta, Ritter and Pizzuto, JJ., concur.
Exhibit 13(a).1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



Pursuant to the requirements of Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Sections 1350(a) and (b)), the undersigned hereby certifies
as follows:



| | 1. |  | I, Vicente Llatas, am the Chief Executive Officer of Compañía Anónima Nacional Teléfonos de Venezuela (CANTV) (the Company);
| | -- |  | ------------------------------------------------------------------------------------------------------------------------------



| | 2. |  | The Companys Annual Report on Form 20-F for the year ended December 31, 2006, accompanying this Certification, in the form filed with the Securities and Exchange
Commission (the Report), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (the Exchange Act), as amended; and
| | -- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 3. |  | The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | -- |  | ------------------------------------------------------------------------------------------------------------------------------------------



Date: May 18, 2007



/s/    VICENTE LLATASName: Vicente LlatasTitle: Chief Executive Officer